TY - JOUR
T1 - Cuba’s COVID-19 Vaccine Enterprise
T2 - Report from a High-Level Fact-Finding Delegation to Cuba
AU - Osterholm, Michael T.
AU - Rabadán-Diehl, Cristina
AU - Anzinger, Joshua
AU - Bottazzi, Maria Elena
AU - Christie-Samuels, Celia
AU - Erondu, Ngozi
AU - Marrazzo, Jeanne
AU - Milan, Sandra
AU - Quashie, Peter Kojo
AU - Schwaab, Thomas
AU - Williams, David
N1 - Funding Information:
Activities of this MED 阀☀☀ fact-finding delegation were supported in part by a grant from the Open Society Foundations. Delegation members issuing the report are solely responsible for its content.
Publisher Copyright:
© 2022 MEDICC Medical Education Cooperation with Cuba. All rights reserved.
PY - 2022/7
Y1 - 2022/7
N2 - In June 2022 an international delegation of scientists from the United States, the Caribbean and Africa traveled to Havana, Cuba for a three-day fact-finding mission to better understand Cuba’s COVID-19 vaccine development and vaccination efforts. It was the first time in five years that a scientific delegation with significant US presence had engaged in discussions with medical researchers in Cuba. It also included African and Caribbean members to ensure there was a diversity of scientific and public health perspectives. Together, delegation members represented a broad range of expertise in public health systems, infectious diseases, biotechnology, and vaccine development.
AB - In June 2022 an international delegation of scientists from the United States, the Caribbean and Africa traveled to Havana, Cuba for a three-day fact-finding mission to better understand Cuba’s COVID-19 vaccine development and vaccination efforts. It was the first time in five years that a scientific delegation with significant US presence had engaged in discussions with medical researchers in Cuba. It also included African and Caribbean members to ensure there was a diversity of scientific and public health perspectives. Together, delegation members represented a broad range of expertise in public health systems, infectious diseases, biotechnology, and vaccine development.
UR - http://www.scopus.com/inward/record.url?scp=85146265083&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146265083&partnerID=8YFLogxK
U2 - 10.37757/MR2022.V24.N3-4.13
DO - 10.37757/MR2022.V24.N3-4.13
M3 - Article
AN - SCOPUS:85146265083
SN - 1555-7960
VL - 24
JO - MEDICC Review
JF - MEDICC Review
IS - 3-4
ER -
